ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Vagi-Hex®:Drossapharm AG
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
G01AX16 - HexetidineATC-DDD Version 2016. Source: WHO
G - Genito Urinary System and Sex Hormones
 
G01 - Gynecological Antiinfectives and Antiseptics

This group comprises gynecological antiinfectives and antiseptics mainly for local use. See also:
J - Antiinfectives for systemic use
D06 - Antibiotics and chemotherapeutics for dermatological use
P01AB - Nitroimidazole derivatives

The DDDs are based on the treatment of vaginal infections.

G01A - Antiinfectives and Antiseptics, Excl. Combinations with Corticosteroids

This group comprises preparations, mainly for local use.
Combinations with corticosteroids, see G01B.
Antivirals for topical use, including gynecological use, such as podophyllotoxin, are classified in D06 - Antibiotics and chemotherapeutics for dermatological use.

G01AX - Other Antiinfectives and Antiseptics

Nifuratel in combination with nystatin is classified in G01AA51.
Vaginal ring with dapiravine for risk reduction of HIV-1 infection is classified here.

G01AX16 - Hexetidine
2024 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home